Please provide your email address to receive an email when new articles are posted on . Abnormal ECG findings were rare in elite female basketball players. These data may serve as a reference for ...

Research shows that a newly-developed wireless EKG patch is as accurate, if not more accurate, than results from traditional EKG machines. The device is known as the EKG Patch Solution. Worldwide, ...

Fitbit has completed clinical trials of its own ECG feature and is looking to get FDA approval – as it launches a large scale study into Afib and irregular heart rate detection. The mass Fitbit Heart ...

(RTTNews) - HeartBeam, Inc., (BEAT), a medical technology company, Tuesday said its synthesized 12-lead electrocardiogram (ECG) met the clinical endpoints in the VALID-ECG pivotal study. The study ...

SANTA CLARA, Calif., April 29, 2025--(BUSINESS WIRE)--HeartBeam, Inc., (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, ...

ROCHESTER, Minn. — Artificial intelligence (AI) from patient electrocardiograms (ECGs) may be an innovative solution to enhance heart disease risk assessment. Atherosclerotic cardiovascular disease — ...

Using electrocardiograms to test the hearts of young athletes before they participate in sports could be a cost-effective way to reduce sudden deaths, a Stanford University study concludes. Questions ...

Mayo Clinic researchers trained artificial intelligence to pick up subtle differences in electrocardiograph readings to diagnose atrial fibrillation with 90% accuracy. Artificial intelligence (AI) can ...

Join our daily and weekly newsletters for the latest updates and exclusive content on industry-leading AI coverage. Learn More Peer-reviewed medical journal JAMA Cardiology today published a study ...

It’s a big week for Google’s wearable plans. Following news that it’s paying $40 million for Fossil technology, parent company Alphabet announced it’s obtained FDA clearance for its electrocardiogram ...

HeartBeam, Inc. (BEAT), (NASDAQ: BEAT), a medical technology company focused on transforming cardiac care by providing powerful personalized insights, today announced that its groundbreaking ...